Observational studyPloS one2023

Long-term effectiveness and safety of infliximab-biosimilar: A multicenter Phoenix retrospective cohort study.

Tomoe Kazama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.